Physician profile
George S Khammar
NPI 1619927373
$6,556.09
in general payments reported to CMS, 2019-2025
38 companies · $1,151 in 2025
The $1,151 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $966 · 2020: $451 · 2021: $640 · 2022: $939 · 2023: $1,458 · 2024: $951 · 2025: $1,151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,559.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,295.42 | 2019-2025 | Avvigo Guidance System, Opticross 6, Synergy |
| Novartis Pharmaceuticals Corporation | $741.40 | 2021-2025 | |
| Shockwave Medical, INC | $614.95 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $607.00 | 2019-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $432.86 | 2019-2021 | |
| Pfizer INC. | $408.56 | 2021-2025 | |
| Heartflow, INC. | $393.80 | 2020-2022 | |
| Abiomed | $307.15 | 2019-2023 | Impella |
| Medtronic, INC. | $304.81 | 2021-2025 | Symplicity G3 |
| Amgen INC. | $178.59 | 2019-2025 | Repatha |
| Medtronic Vascular, INC. | $134.33 | 2019-2020 | |
| Biotronik INC. | $123.89 | 2024 | Orsiro Mission |
| Inspire Medical Systems, INC. | $121.31 | 2024-2025 | Inspire |
| Cardiovascular Systems INC. | $90.11 | 2019 | |
| Abbott Laboratories | $79.46 | 2021-2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $75.24 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Actelion Pharmaceuticals US, INC. | $72.23 | 2024-2025 | Uptravi |
| Inari Medical, INC. | $59.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $57.25 | 2020-2024 | Xarelto |
| Ge Healthcare | $55.50 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.36 | 2023-2025 | Lifevest |
| Philips North America LLC | $31.33 | 2024-2025 | (Ck4) Mcot, Mcot |
| Ebr Systems, INC. | $31.23 | 2025 | |
| Amarin Pharma, INC. | $29.61 | 2021 | |
| Daiichi Sankyo INC. | $29.24 | 2023 | Injectafer |
| Angiodynamics, INC. | $26.88 | 2025 | Auryon Laser System 100-120 Vac |
| Astrazeneca Pharmaceuticals LP | $24.24 | 2019-2021 | |
| Kiniksa Pharmaceuticals, LTD. | $20.25 | 2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.34 | 2022 | |
| Vital Connect, INC | $18.98 | 2025 | Vitalpatch Rtm |
| Sanofi-Aventis U.S. LLC | $18.65 | 2019 | |
| Medline Industries LP | $16.92 | 2019 | |
| Terumo Medical Corporation | $16.83 | 2021 | |
| Chiesi USA, INC. | $16.75 | 2021 | |
| Atricure, INC. | $15.23 | 2023 | |
| Siemens Medical Solutions USA, INC. | $12.59 | 2021 | |
| Avinger INC. | $12.54 | 2022 | |
| Novo Nordisk INC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Khammar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.